SCHEMBL538549

SCHEMBL538549

CCCCCCCCCCCCCCCCCCOC(CCCCCCCCCCCCCCCC)(COCCC(C)Oc1ccc2c(c1)C(=O)c1ccccc1-2)OCCCCCCCCCCCCCCCCCC

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.38
KMT2A Q03164 3/20 0.38
L3MBTL1 Q9Y468 3/20 0.38
NPC1 O15118 3/20 0.38
RAB9A P51151 3/20 0.38
ALDH1A1 P00352 2/20 0.38
MEN1 O00255 1/20 0.38
GAA P10253 1/20 0.38
PTPN1 P18031 2/20 0.37
PTPN11 Q06124 1/20 0.37
POLB P06746 1/20 0.34
DNMT1 P26358 1/20 0.34
RAD52 P43351 1/20 0.34
PDK2 Q15119 2/20 0.33
LMNA P02545 2/20 0.33
MAPK1 P28482 2/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
MCHR1 Q99705 1/20 0.32
CHRNA7 P36544 1/20 0.32
CASP3 P42574 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL538548 0.79 MAPT (0.41) MAPTKMT2AL3MBTL1NPC1RAB9A
SCHEMBL538809 0.79 PDK2 (0.41) PTPN11PDK2
SCHEMBL539159 0.78 PDK2 (0.37) PDK2
SCHEMBL538547 0.75 MAPT (0.51) MAPTKMT2AL3MBTL1NPC1RAB9A
SCHEMBL15470837 0.73 MAPT (0.49) MAPTKMT2AL3MBTL1NPC1RAB9A
SCHEMBL13165928 0.73 MAPT (0.51) MAPTKMT2AL3MBTL1NPC1RAB9A
SCHEMBL538615 0.72 MAPT (0.67) MAPTKMT2AL3MBTL1NPC1RAB9A
SCHEMBL538564 0.72 MAPT (0.62) MAPTKMT2AL3MBTL1NPC1RAB9A
SCHEMBL23960774 0.71 MAPT (0.64) MAPTKMT2AL3MBTL1NPC1RAB9A
SCHEMBL15470811 0.71 MAPT (0.51) MAPTKMT2AL3MBTL1NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9029504-B2 Fluorene compound AJINOMOTO CO., INC. (JP) 2015-05-12 US disclosed
US-20140046022-A1 FLUORENE COMPOUND AJINOMOTO CO., INC. (JP) 2014-02-13 US disclosed
US-8569453-B2 Fluorene compound AJINOMOTO CO., INC. (JP) 2013-10-29 US disclosed
EP-2415744-A1 FLUORENE COMPOUND Ajinomoto Co., Inc. (JP) 2012-02-08 EP disclosed
US-20100240867-A1 FLUORENE COMPOUND AJINOMOTO CO. INC. (JP) 2010-09-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140046022-A1 FLUORENE COMPOUND NPPA, FURIN, SFPQ MAPT 656/4885KMT2A 2658/4885L3MBTL1 571/4885
US-20100240867-A1 FLUORENE COMPOUND NPPA, FURIN, SFPQ MAPT 656/4885KMT2A 2658/4885L3MBTL1 571/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.